gimli
TORNTPHARM stock analysis context
TORRENT PHARMACEUTICALS L Stock Context for AI Screening
TORRENT PHARMACEUTICALS L is a large-cap stock in Healthcare. This page summarizes key screening signals for TORRENT PHARMACEUTICALS L, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about TORNTPHARMPrice
₹4,486.20
1M return
+9.83%
3M return
+5.76%
Market cap
₹151,833.38 cr
PE
66.82
ROE
+31.46%
RSI
61.90
Turnover
₹92.38 cr
Why it can matter in screens
- Momentum: TORNTPHARM is above 50DMA, above 200DMA; RSI is 61.90.
- Returns: 1M +9.83%, 3M +5.76%, 6M +21.69%.
- Liquidity: latest turnover is ₹92.38 cr.
- Valuation: PE 66.82, PB n/a, ROE +31.46%, ROCE +29.64%.
- Growth: 3Y sales CAGR +10.36%, 3Y profit CAGR +34.97%.
Try these prompts
- Analyze TORRENT PHARMACEUTICALS L with valuation, momentum and industry peers
- Compare TORNTPHARM with other Healthcare stocks
- Show large-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View large-cap stocks
- Find stocks above 50DMA
- Compare TORNTPHARM with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.